Anxiety study: Teleo vs Standard Videoconferencing
Official title Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
ClinicalTrials.gov ID: NCT07155707
What this study is testing
- What it's testing
- This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 14
You may be able to join if
- Diagnosed with a mood and/or anxiety disorder
- Have proficiency to participate in psychotherapy in English
- Scheduled to begin therapy at one of the study sites
- RCADS score \> 65
You likely can't join if
- \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate...
The study team makes the final eligibility decision.
Where it is enrolling
- Stanford, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 14 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Stanford, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.